Pharmicell Co., Ltd.

ACTIVE

7/F Ssangbong Bldg., Seoul, South Koreawww.pharmicell.comPublic136 employees

Also known as:

pharmicell co., ltd._seongnam factory

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

33.3%

Phase 2

16.7%

Not Applicable

11.1%

Phase 3

11.1%

Trial Status Distribution

Active, not recruiting

5.6%

Completed

38.9%

Recruiting

22.2%

Terminated

16.7%

Unknown

11.1%

Withdrawn

5.6%

Clinical Trials

Trials sponsored by this organization (18)

Safety Follow-up Study of Cellgram-ED in Post-Radical Prostatectomy Erectile Dysfunction

Recruiting

observational

Dec 202432 participants

Long-Term Follow-up of Patients With Chronic Kidney Disease Treated With Cellgram-CKD

Active, not recruiting

observational

Mar 202210 participants

Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration

Not Applicable

Recruiting

interventional

Mar 2022100 participants

A Phase 1 Study of Cellgram-DC in Patients With Advanced or Recurrent Epithelial Ovarian Cancer

Phase 1

Terminated

interventional

Feb 20222 participants

Phase 1 Study of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Chronic Kidney Disease

Phase 1

Completed

interventional

Nov 202110 participants

Long-Term Follow-up of Patients With Alcoholic Liver Cirrhosis Treated With Cellgram-LC

Not Applicable

Recruiting

observational

Sep 2021100 participants

A Phase 1 Study of Autologous Dendritic Cell Immunotherapy in Patients With mCRPC

Phase 1

Terminated

interventional

Jul 20213 participants

Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis

Phase 3

Recruiting

interventional

Apr 2021200 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

Back to Organizations